Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

HHS Internet Pharmacy Certification Would Involve Existing Programs

Executive Summary

The Clinton administration's Internet pharmacy certification bill would allow HHS to work with existing certification programs for Internet pharmacy sites.

You may also be interested in...



State AGs Need Power To Pursue Online Pharmacies In Federal Court - Bliley

State Attorneys General would be given authority to seek injunctions against companies illegally selling prescription drugs over the Internet in federal court under legislation to be introduced by Commerce Committee Chairman Bliley (R-Va.) and Commerce/Oversight & Investigations Subcommittee Chairman Upton (R-Mich.).

State AGs Need Power To Pursue Online Pharmacies In Federal Court - Bliley

State Attorneys General would be given authority to seek injunctions against companies illegally selling prescription drugs over the Internet in federal court under legislation to be introduced by Commerce Committee Chairman Bliley (R-Va.) and Commerce/Oversight & Investigations Subcommittee Chairman Upton (R-Mich.).

Internet Pharmacy Hearing To Question FDA Progress In Curbing Illegal Sales

The House Commerce/Oversight & Investigations Subcommittee will hold a hearing May 25 to examine FDA's progress in controlling illegal Internet drug sales in the 10 months since the agency last appeared before the subcommittee.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS035996

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel